Rambus Inc. (RMBS) Forms $10.33 Double Bottom; Shorts at Invivo Therapeutics Holdings (NVIV) Lowered By 11.19%

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) Logo

Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) had a decrease of 11.19% in short interest. NVIV’s SI was 249,300 shares in March as released by FINRA. Its down 11.19% from 280,700 shares previously. With 35,800 avg volume, 7 days are for Invivo Therapeutics Holdings Corp (NASDAQ:NVIV)’s short sellers to cover NVIV’s short positions. The SI to Invivo Therapeutics Holdings Corp’s float is 2.68%. The stock increased 1.85% or $0.03 during the last trading session, reaching $1.65. About 126,643 shares traded or 107.77% up from the average. InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) has declined 87.15% since March 12, 2018 and is downtrending. It has underperformed by 91.52% the SP500. Some Historical NVIV News: 20/03/2018 – ClinicalTrial US: Cannabidiol – an in Vivo Innovative Drug Delivery Study; 09/04/2018 – lnVivo Therapeutics Provides Business

... read more at: https://finexaminer.com/2019/03/12/rambus-inc-rmbs-forms-10-33-double-bottom-shorts-at-invivo-therapeutics-holdings-nviv-lowered-by-11-19/